Pig liver trial offers hope for liver failure patients
Disease control
Not yet recruiting
This early-stage study tests a genetically-modified pig liver (EGEN-5784) used outside the body with a special device to temporarily support liver function in 20 adults with acute-on-chronic liver failure. Participants are not eligible for a transplant. The goal is to check safet…
Phase: PHASE1 • Sponsor: eGenesis, INC • Aim: Disease control
Last updated May 17, 2026 08:50 UTC